M33 Growth I Gp LLC and 2 Others Sells $20.7M of Oncology Institute Inc (TOI) — SEC Form 4, Sep 05, 2025

Open-Market Net Sale · SEC Form 4
−$20,703,000

Equity position changed by -44.0%

Reporting Owners
Director 10% Owner
Director 10% Owner
Director 10% Owner
TXN 2025-09-04 · FILED 2025-09-05
Equity Position 8.52M sh 15,223,281 → 8,523,281
Equity Change -44.0% shares held after vs before
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2025-09-05
Report Date
2025-09-05
Accession No.
0001213900-25-084700
Accepted At
2025-09-05 10:12 UTC
Reporting Owners
Name Relationship
M33 Growth I Gp LLC CIK 0001894303
Director 10% Owner
M33 Growth I L.P. CIK 0001718621
Director 10% Owner
Toi M, LLC CIK 0001892968
Director 10% Owner
M33 Growth I Gp LLC at Oncology Institute Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Oncology Institute Inc
2025-11-20 Gift/Other — View
2025-06-09 Sell -$2,287,500 View
2025-05-22 Sell -$5,425,800 View
2025-03-28 Award — View
All filings by this insider at Oncology Institute Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1 2025-09-04 S - Sale 6,018,168 D $3.09 -$18,596,139 7,932,389 Direct
Common StockF2 2025-09-04 S - Sale 681,832 D $3.09 -$2,106,861 590,892 Indirect See Footnote
Footnotes (2)
F1
M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein. Show more
F2
These securities are held by TOI M, LLC. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at Oncology Institute Inc
All Oncology Institute Inc insider activity
GET /v1/forms/4/0001213900-25-084700 API docs
View Original SEC Filing